Insilico at AACR: Showcasing Four Groundbreaking Posters Highlighting the Potential of Generative AI
Insilico Medicine Accelerates Oncology Innovation with Four Novel AI-Designed Programs Unveiled at AACR 2026 In a striking demonstration of the ...
Tag: AI-driven drug discovery
Researchers from Insilico Medicine and Lilly Unveil Groundbreaking Vision for Fully Autonomous “Prompt-to-Drug” Pharmaceutical R&D in ACS Central Science
In a groundbreaking publication poised to redefine the future of drug discovery, researchers from Insilico Medicine and Lilly have unveiled ...
Insilico Medicine Launches AI-Powered Partnership with Top Global Cancer Center to Uncover New Targets in Gastroesophageal Cancer
In a groundbreaking alliance set to redefine therapeutic discoveries for gastroesophageal cancers, Insilico Medicine, an industry leader in AI-driven drug ...
Insilico Medicine and CMS Forge Multiple Collaborations to Accelerate AI-Driven R&D in CNS and Autoimmune Disorders
In a groundbreaking announcement set to redefine the future of pharmaceutical innovation, Insilico Medicine and China Medical System Holdings Limited ...
Insilico Medicine Selects ISM5059, a Peripheral-Restricted NLRP3 Inhibitor, as Preclinical Candidate
In a groundbreaking development within the realm of anti-inflammatory therapeutics, Insilico Medicine, a clinical-stage pioneer harnessing the power of generative ...
AI-Driven Doxycycline Assessment Targets 16S rRNA Methyltransferase
In an era where artificial intelligence is reshaping the landscape of drug discovery, researchers are increasingly leaning towards innovative methodologies ...
Vanderbilt Researcher Overcomes Major Challenge in AI-Driven Drug Discovery
In the relentless quest to accelerate drug discovery and reduce astronomical costs, researchers are increasingly turning to machine learning to ...
AI-Driven Discovery of GSK3β Inhibitors via Virtual Screening
In recent years, the field of drug discovery has experienced a significant paradigm shift, largely driven by advances in computational ...
AI-Driven Design and Testing of Topoisomerase I Inhibitors
In a groundbreaking study that merges the capabilities of machine learning with the field of medicinal chemistry, researchers have embarked ...
Insilico Medicine’s Chemistry42 Drives Discovery of Novel Chemotype Pan-KRAS Inhibitors – ACS Medicinal Chemistry Letters
In a significant breakthrough that harnesses the cutting-edge capabilities of artificial intelligence (AI) in drug discovery, Insilico Medicine, a leading ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!